Across TCGA pan-cancer cohorts, ZNF733P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of ZNF733P’s most consistent transcriptional readouts.

The strongest signal is observed in prostate adenocarcinoma (PRAD), where ZNF733P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ZNF733P is over-expressed in tumor.

PRAD and LIHC are the cancer types where ZNF733P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ZNF733P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PRAD	All	All	+0.003	.041	2	view →
LIHC	All	All	+0.014	.035	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: ZNF733P RNA expression & survival · all ZNF733P data types